News | January 07, 2024
Pharmaids Pharmaceuticals to acquire Adita Bio Sys in share swap
The acquisition of the shares of Adita result in growth opportunities in line with strategic objectives of the company
The acquisition of the shares of Adita result in growth opportunities in line with strategic objectives of the company
Emphasizes the need for a collective effort on bolstering resilience across economies, societies, healthcare systems, education systems and infrastructure
PhytoSquene now available for clinical and commercial use
Biologics manufacturing to expand the Aragen platform by offering “gene to GMP” solution
The company expects that this development could improve the strength of its application to the FDA for new drug approval
Pant delivers keynote address at National Conclave on “Augmented Zoonotic Diseases Surveillance at Human – Wildlife Interface”
Seamless transition from preclinical to first-in-human trials with EUDRACAP platform technology
Senvelgo is the first liquid once-daily, orally administered prescription medication to improve glycemic control in cats with diabetes mellitus
US FDA approval is in line with de-risking strategy for additional API site to service our global customer base
Preclina is renowned for its highly specialized services in autoimmune and inflammatory disorders
Subscribe To Our Newsletter & Stay Updated
